MC4R and Hepatic fibrosis: Whereas CANA did not attenuate hepatic TG content in WD-fed MC4R-KO mice after treatment for 52 weeks (Fig. 5e), CANA significantly reduced liver fibrosis (Fig. 5f and g) and serum ALT levels (Fig. 5h).